[1]刘静,陆德铭.陆德铭教授谈乳腺癌与情志[J].西部中医药,2016,29(07):49-51.
　LIU Jing,LU Deming.Professor LU Deming′s Opinion about Breast Cancer and Emotion[J].Western Journal of Traditional Chinese Medicine,2016,29(07):49-51.
点击复制

陆德铭教授谈乳腺癌与情志
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
29
期数:
2016年07期
页码:
49-51
栏目:
出版日期:
2016-07-15

文章信息/Info

Title:
Professor LU Deming′s Opinion about Breast Cancer and Emotion
文章编号:
1004-6852(2016)07-0049-03
作者:
刘静1，陆德铭2
1 上海中医药大学附属市中医医院/上海市中医医院，上海 200071； 2 上海中医药大学附属龙华医院
Author(s):
LIU Jing1, LU Deming2
1 Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai 200071, China;2 Longhua Hospital Shanghai University of TCM
关键词:
乳腺癌; 情志内伤; 陆德铭
Keywords:
breast cancer;  emotional injuries;  Lu Deming
分类号:
R737.9
文献标志码:
A
摘要:
陆德铭教授治疗乳腺癌重视情志因素，认为情志内伤与乳腺癌互为因果，情志内伤是乳腺癌的致病因素之一，反之乳腺癌也会引起或加重情志内伤，因此陆德铭教授从心、肝、脾3脏着手，燮理气血，辨证治疗乳腺癌情志内伤。
Abstract:
Professor Lu Deming values emotional factors during the period of treating breast cancer, he thought that emotional injury and breast cancer could affect each other, emotional injury was one of the pathogenic factor of breast cancer, otherwise breast cancer would cause or aggravate emotional injury. Based on syndrome differentiation, professor Lu treats breast cancer from three aspects: heart, liver and spleen, and by regulating Qi-blood.

相似文献/References:

[1]王斌,王艳杰,梁贵文,等.乳积方防治乳腺癌患者术后复发转移的临床研究*[J].西部中医药,2013,26(08):101.
　WANG Bin,WANG Yanjie,LIANG Guiwen,et al.Clinical Study on RuJiFang to Prevent Postoperative Recurrence and Metastasis of Breast Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(07):101.
[2]侯俊明,江静.疏肝解郁法联合化疗治疗乳腺癌临床疗效分析[J].西部中医药,2014,27(09):1.
[3]王丽,何丽娟,朱玉芹.循证护理对乳腺癌化疗患者自尊水平和应对方式的影响[J].西部中医药,2014,27(11):134.
[4]朱慧华.纽曼护理对乳腺癌手术患者心理健康和生活质量的影响[J].西部中医药,2014,27(12):105.
[5]张晓华,张晓岚△,梁玉荣,等.综合心理干预对乳腺癌化疗患者医学应对方式及生命质量的影响[J].西部中医药,2015,28(07):123.
[6]谷雨,华海清△.中医辨证分型与乳腺癌预后的相关性研究[J].西部中医药,2015,28(04):85.
[7]刘琛,吴黎雅,赵红佳,等.人参养荣汤干预乳腺癌新辅助化疗所致气血两虚证的临床研究[J].西部中医药,2011,24(11):3.
[8]李树建.扶正祛积汤联合CEF化疗方案治疗晚期乳腺癌40例临床研究[J].西部中医药,2013,26(09):1.
　LI Shujian.Clinical Study on FuZheng QuJiTang Combined with CEF Chemotherapy in Treating 40 Patients Suffering from Advanced Mammary Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(07):1.
[9]安妮,杨俊兰.消 疒徵祛积方联合化疗对晚期乳腺癌患者血清CEA、CA125、CA153和CA19-9含量及临床疗效的影响[J].西部中医药,2013,26(03):7.
　AN Ni,YANG Junlan.Effects of XiaoZhen QuJiFang and Chemotherapy on Clinical Efficacy and Contents of Serum CEA, CA125, CA153 and CA19-9 of Patients with Mammary Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(07):7.
[10]朱竹华,许敏菊,张汀荣,等.以家庭为中心的护理模式在完全植入式静脉输液港乳腺癌化疗患者中的应用[J].西部中医药,2016,29(03):114.
　ZHU Zhuhua,XU Minju,ZHANG Dingrong,et al.FCC Applying to Breast Cancer Patients Who Received Chemotherapy by TIVAP[J].Western Journal of Traditional Chinese Medicine,2016,29(07):114.

备注/Memo

备注/Memo:
收稿日期：2015-09-23 *基金项目：上海市卫生和计划生育委员会中医药继承专项研究课题(编号2014S25)。 作者简介：刘静(1971—)，女，硕士研究生导师，主任医师，副教授。研究方向：恶性肿瘤的中西医结合治疗。
更新日期/Last Update: 2016-07-15